Cladribine, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) regimen

DRUG2 trials

Sponsors

Medical College of Wisconsin, H. Lee Moffitt Cancer Center and Research Institute

Conditions

Acute Myeloid LeukemiaMyelodysplastic SyndromeRelapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 2

Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

TerminatedNCT03150004

Medical College of WisconsinAcute Myeloid Leukemia, Myelodysplastic Syndrome

Start: 2017-06-14End: 2025-03-14Updated: 2026-03-30

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

RecruitingNCT06660368

H. Lee Moffitt Cancer Center and Research InstituteRelapsed or Refractory Acute Myeloid Leukemia (AML)

Start: 2024-11-26End: 2027-11-01Target: 52Updated: 2026-04-01